Sei Investments CO Jounce Therapeutics, Inc. Transaction History

Sei Investments CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 12, 2021	SELL	$6.73 - $13.87 $262,032 - $540,028	-38,935 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$6.37 - $10.33 $625,680 - $1.01 Million	-98,223 Reduced 71.61%	38,935 $273,000
Q3 2020 Nov 06, 2020	SELL	$4.58 - $10.95 $3,453 - $8,256	-754 Reduced 0.55%	137,158 $1.12 Million
Q2 2020 Aug 17, 2020	BUY	$4.17 - $7.58 $411,774 - $748,502	98,747 Added 252.13%	137,912 $949,000
Q2 2020 Aug 11, 2020	SELL	$4.17 - $7.58 $282,171 - $512,915	-67,667 Reduced 63.34%	39,165 $338,000
Q1 2020 May 14, 2020	BUY	$2.91 - $8.7 $199,105 - $595,262	68,421 Added 178.13%	106,832 $507,000
Q4 2019 Feb 06, 2020	BUY	$2.81 - $9.21 $107,934 - $353,765	38,411 New	38,411 $335,000
Q1 2018 May 11, 2018	SELL	$13.4 - $28.4 $415 - $880	-31 Closed	0 $0
Q3 2017 Nov 06, 2017	BUY	$11.17 - $16.99 $346 - $526	31	31 $0

720K

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.